Survey to Evaluate the Effectiveness of Risk Minimisation Measures for Atezolizumab Use in the European Union

First published 07/12/2017

Last updated 02/07/2024

EU PAS number:

EUPAS21920

Study

Finalised

Documents

Study protocol

Initial protocol

WO40486_Protocol_11 Dec 2018_Redacted

English (1.58 MB - PDF) View document

Updated protocol

Prot WO40486 Tecentriq v1_Redacted

First published: 22/02/2024

English (1.85 MB - PDF) View document

Study results

Final_CSR_Study_WO40486__Published_Output-1_CSR_Synopsis_Redacted

English (1.08 MB - PDF) View document

Study report

Other information

Secondary tabs